Sort by
Refine Your Search
-
Program
-
Field
-
biology, engineering, biophysics, computer science) and experience in 3D imaging of brain tissue, image segmentation, and handling large datasets. You are comfortable with machine learning and image
-
of manufacturing. We have identified an opportunity to combine continuous microfluidic (µF) process models, process analytical technology (PAT) and machine learning (ML) to achieve a paradigm shift in bioprocess
-
TypeHybridAvailable for SecondmentNoClosing Date07-Nov-2025 The UCL Centre for Radiopharmaceutical Chemistry (CRC) is a multidisciplinary research centre dedicated to the development and clinical translation of novel
-
About us The UCL Centre for Radiopharmaceutical Chemistry (CRC) is a multidisciplinary research centre dedicated to the development and clinical translation of novel biomedical imaging agents
-
volunteers and one in patient populations. Be involved in all aspects of the research: recruitment, data collection, management, public and patient involvement, imaging processing, and analysis. Liaise with
-
benefit from the extensive and broad expertise in AI and biomedical computing at the School of Biomedical Engineering & Imaging Sciences. The work will be done in close collaboration with a
-
volunteers and one in patient populations. Be involved in all aspects of the research: recruitment, data collection, management, public and patient involvement, imaging processing, and analysis. Liaise with
-
expertise in AI and biomedical computing at the School of Biomedical Engineering & Imaging Sciences. The work will be done in close collaboration with a multidisciplinary team at KCL, UCL and with clinicians
-
bronchoscopy programmes for patients with premalignant changes in their lung. We offer a rapid diagnostics clinic in the UCLH Macmillan Cancer Centre, which includes state-of-the-art imaging with computed
-
biomarker collection and MRI imaging. Both the EJS ACT-PD Trial and Initiative are led by Professor Camille Carroll (Newcastle University, Co-Chief investigator) and Professor Thomas Foltynie (UCL, Co-Chief